Literature DB >> 8168917

Pathological significance and molecular characterization of the vacuolating toxin gene of Helicobacter pylori.

S H Phadnis1, D Ilver, L Janzon, S Normark, T U Westblom.   

Abstract

Some strains of Helicobacter pylori are known to produce an extracellular cytotoxin that causes vacuolization in various mammalian cells. In this study, we found that concentrated culture supernatants from four Helicobacter strains isolated from patients infected with the bacterium, but having normal gastric mucosa, lacked cytotoxic activity. We also show that a higher percentage of strains isolated from patients with polymorphonuclear leukocyte infiltration of gastric mucosa are toxin positive (78%) versus those isolated from patients lacking such infiltration (33%). In addition to examining the relationship between pathology and cytotoxic activity, we used the previously published N-terminal sequence of the protein to clone and characterize vacA, the structural gene encoding the cytotoxin. Briefly, three oligonucleotides capable of encoding the first nine amino acids corresponding to the sense strand and four oligonucleotides corresponding to the noncoding strand of the last seven known amino acids of the cytotoxin protein were made. They were used in all 12 possible combinations in 12 different PCR reactions, with DNA from a cytotoxin-positive strain as template. In four combinations, the expected 69-bp fragment was seen. The sequence of this 69-bp fragment confirmed that it encoded the known N-terminal sequence of the cytotoxin. This gene is capable of encoding a 136-kDa protein with a 33-amino-acid signal peptide, whereas the purified cytotoxin is only 87 kDa, suggesting processing in the C-terminal region of the protein. A single copy of the vacA gene encodes the cytotoxin in H. pylori. Consequently, the insertion of a kanamycin resistance marker in the vacA gene produced an isogenic mutant lacking the cytotoxic activity. This mutant provides genetic evidence that vacA encodes the cytotoxin. Sequence analysis of the DNA adjacent to the vacA gene demonstrated that this gene is next to a putative cysteinyl tRNA synthetase gene. From the sequence arrangement, we predict that there are no other genes transcribed together with vacA. We also show that five of seven cytotoxin-negative strains examined still carry the sequences encoding it whereas the other two have suffered a deletion of the vacA gene. We further show that in at least one cytotoxin-negative but vacA-positive strain (MO19), there are variations in the length of the vacA gene that could explain the cytotoxin-negative phenotype in this strain.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8168917      PMCID: PMC186356          DOI: 10.1128/iai.62.5.1557-1565.1994

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  21 in total

1.  Basic local alignment search tool.

Authors:  S F Altschul; W Gish; W Miller; E W Myers; D J Lipman
Journal:  J Mol Biol       Date:  1990-10-05       Impact factor: 5.469

2.  An enzyme with type IV prepilin peptidase activity is required to process components of the general extracellular protein secretion pathway of Klebsiella oxytoca.

Authors:  A P Pugsley; B Dupuy
Journal:  Mol Microbiol       Date:  1992-03       Impact factor: 3.501

3.  Purification and characterization of the vacuolating toxin from Helicobacter pylori.

Authors:  T L Cover; M J Blaser
Journal:  J Biol Chem       Date:  1992-05-25       Impact factor: 5.157

4.  PCR amplification of up to 35-kb DNA with high fidelity and high yield from lambda bacteriophage templates.

Authors:  W M Barnes
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-15       Impact factor: 11.205

5.  Histologic characteristics of Campylobacter pylori (Helicobacter pylori) mediated gastritis.

Authors:  E Madan; J Kemp; T U Westblom; J Chaffin; A M Foster
Journal:  Ann Clin Lab Sci       Date:  1990 Sep-Oct       Impact factor: 1.256

6.  Bafilomycin A1 inhibits Helicobacter pylori-induced vacuolization of HeLa cells.

Authors:  E Papini; M Bugnoli; M De Bernard; N Figura; R Rappuoli; C Montecucco
Journal:  Mol Microbiol       Date:  1993-01       Impact factor: 3.501

7.  Construction of isogenic urease-negative mutants of Helicobacter pylori by allelic exchange.

Authors:  R L Ferrero; V Cussac; P Courcoux; A Labigne
Journal:  J Bacteriol       Date:  1992-07       Impact factor: 3.490

8.  Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii.

Authors:  A Nomura; G N Stemmermann; P H Chyou; I Kato; G I Perez-Perez; M J Blaser
Journal:  N Engl J Med       Date:  1991-10-17       Impact factor: 91.245

9.  Helicobacter pylori infection and the risk of gastric carcinoma.

Authors:  J Parsonnet; G D Friedman; D P Vandersteen; Y Chang; J H Vogelman; N Orentreich; R K Sibley
Journal:  N Engl J Med       Date:  1991-10-17       Impact factor: 91.245

10.  Use of polymerase chain reaction-amplified Helicobacter pylori urease structural genes for differentiation of isolates.

Authors:  P A Foxall; L T Hu; H L Mobley
Journal:  J Clin Microbiol       Date:  1992-03       Impact factor: 5.948

View more
  74 in total

1.  Vacuolating cytotoxin (vacA) alleles of Helicobacter pylori comprise two geographically widespread types, m1 and m2, and have evolved through limited recombination.

Authors:  J C Atherton; P M Sharp; T L Cover; G Gonzalez-Valencia; R M Peek; S A Thompson; C J Hawkey; M J Blaser
Journal:  Curr Microbiol       Date:  1999-10       Impact factor: 2.188

2.  Analysis of Helicobacter pylori vacA gene and serum antibodies to VacA in Japan.

Authors:  D Shirasaka; N Aoyama; K Satonaka; K Shirakawa; H Yoshida; T Sakai; T Ikemura; Y Shinoda; M Sakashita; M Miyamoto; K Yahiro; A Wada; H Kurazono; T Hirayama; M Kasuga
Journal:  Dig Dis Sci       Date:  2000-04       Impact factor: 3.199

3.  Mutational analysis of the Helicobacter pylori vacuolating toxin amino terminus: identification of amino acids essential for cellular vacuolation.

Authors:  D Ye; S R Blanke
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

4.  Detection of serum antibodies to CagA and VacA and of serum neutralizing activity for vacuolating cytotoxin in patients with Helicobacter pylori-induced gastritis.

Authors:  M Donati; S Moreno; E Storni; A Tucci; L Poli; C Mazzoni; O Varoli; V Sambri; A Farencena; R Cevenini
Journal:  Clin Diagn Lab Immunol       Date:  1997-07

5.  High-level genetic diversity in the vapD chromosomal region of Helicobacter pylori.

Authors:  P Cao; T L Cover
Journal:  J Bacteriol       Date:  1997-05       Impact factor: 3.490

6.  Plasma membrane cholesterol modulates cellular vacuolation induced by the Helicobacter pylori vacuolating cytotoxin.

Authors:  Hetal K Patel; David C Willhite; Rakhi M Patel; Dan Ye; Christopher L Williams; Eric M Torres; Kent B Marty; Robert A MacDonald; Steven R Blanke
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

7.  Fluorescence resonance energy transfer microscopy of the Helicobacter pylori vacuolating cytotoxin within mammalian cells.

Authors:  David C Willhite; Dan Ye; Steven R Blanke
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

8.  Differences in genome content among Helicobacter pylori isolates from patients with gastritis, duodenal ulcer, or gastric cancer reveal novel disease-associated genes.

Authors:  Carolina Romo-González; Nina R Salama; Juan Burgeño-Ferreira; Veronica Ponce-Castañeda; Eduardo Lazcano-Ponce; Margarita Camorlinga-Ponce; Javier Torres
Journal:  Infect Immun       Date:  2009-02-23       Impact factor: 3.441

9.  Cloning and characterization of hemolytic genes from Helicobacter pylori.

Authors:  E S Drazek; A Dubois; R K Holmes; D Kersulyte; N S Akopyants; D E Berg; R L Warren
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

10.  Inability of an isogenic urease-negative mutant stain of Helicobacter mustelae to colonize the ferret stomach.

Authors:  K A Andrutis; J G Fox; D B Schauer; R P Marini; J C Murphy; L Yan; J V Solnick
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.